R1 RCMRCM
Market Cap: $5.94B
About: R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
Employees: 30,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
43% more funds holding in top 10
Funds holding in top 10: 7 [Q1] → 10 (+3) [Q2]
26% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 38
4% more funds holding
Funds holding: 255 [Q1] → 265 (+10) [Q2]
8% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 85
0.91% more ownership
Funds ownership: 57.35% [Q1] → 58.26% (+0.91%) [Q2]
1% less capital invested
Capital invested by funds: $3.1B [Q1] → $3.08B (-$24.3M) [Q2]
97% less call options, than puts
Call options by funds: $2.41M | Put options by funds: $78.4M
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target | 2%upside $14.30 | Neutral Reiterated | 20 Aug 2024 |
Truist Securities Jailendra Singh 52% 1-year accuracy 17 / 33 met price target | 2%upside $14.30 | Hold Maintained | 8 Aug 2024 |
TD Cowen Charles Rhyee 29% 1-year accuracy 2 / 7 met price target | 2%upside $14.30 | Hold Downgraded | 5 Aug 2024 |
Leerink Partners Michael Cherny 50% 1-year accuracy 12 / 24 met price target | 2%upside $14.30 | Market Perform Downgraded | 1 Aug 2024 |
Canaccord Genuity Richard Close 47% 1-year accuracy 14 / 30 met price target | 7%upside $15 | Buy Maintained | 22 Jul 2024 |
Financial journalist opinion
Based on 3 articles about RCM published over the past 30 days